Cargando…

Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation

BACKGROUND: Thyroid incidentaloma is defined as an unsuspected thyroid lesion found on imaging study or while performing a surgery non-related to the thyroid gland. Most recent scientific literature tends to demonstrate a detection rate of 0.1–4.3% for incidental findings of thyroid focal uptake ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagenimana, N., Dallaire, J., Vallée, É., Belzile, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359908/
https://www.ncbi.nlm.nih.gov/pubmed/28320460
http://dx.doi.org/10.1186/s40463-017-0200-8
_version_ 1782516482881617920
author Hagenimana, N.
Dallaire, J.
Vallée, É.
Belzile, M.
author_facet Hagenimana, N.
Dallaire, J.
Vallée, É.
Belzile, M.
author_sort Hagenimana, N.
collection PubMed
description BACKGROUND: Thyroid incidentaloma is defined as an unsuspected thyroid lesion found on imaging study or while performing a surgery non-related to the thyroid gland. Most recent scientific literature tends to demonstrate a detection rate of 0.1–4.3% for incidental findings of thyroid focal uptake identified by (18)F-fluorodeoxyglugose Positron Emission Tomography with computed tomography ((18)FDG-PET/CT) initially prescribed for nonthyroid disease. From 10.3 to 80.0% of patients who underwent further evaluation are diagnosed with malignant lesions. Our first objective is to determine the risk of malignancy confined in thyroid incidentalomas(IT) detected on (18)FDG-PET/CT in patients treated in a tertiary care center (Centre Hospitalier Universitaire de Sherbrooke). Second, we want to identify a cut-off value for SUVmax in order to distinguish benign from malignant IT. Third, we look for predictive criterion that can be outlined to help in their management. METHODS: We retrospectively reviewed 40 914 charts of patients who had a (18)FDG-PET/CT done in a tertiary center from 2004 to 2014. For each patient where a thyroid incidentaloma has been identified, Maximum Standardized Uptake Value (SUVmax), ultrasound report, cytology and histopathological results as well as oncologic outcomes were compiled and analyzed. RESULTS: In this study, the incidence for thyroid incidentaloma detected with (18)FDG-PET/CT is 0.74%. The rate of malignancy present in IT is 8.2% based on histopathological results. Of the patients who underwent surgery, thyroid malignancy was identified in 54.3% of them. Cytoponction showed a strong correlation with final histopathological results (p = 0.009). CONCLUSION: Thyroid incidentalomas detected with (18)FDG-PET/CT are relatively infrequent, but the potential risk of malignancy remains elevated. Fine needle aspiration biopsy is the investigation of choice to rule out a malignant incidentaloma when there is no other element in the clinical portrait to preclude such additional work up.
format Online
Article
Text
id pubmed-5359908
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53599082017-03-22 Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation Hagenimana, N. Dallaire, J. Vallée, É. Belzile, M. J Otolaryngol Head Neck Surg Original Research Article BACKGROUND: Thyroid incidentaloma is defined as an unsuspected thyroid lesion found on imaging study or while performing a surgery non-related to the thyroid gland. Most recent scientific literature tends to demonstrate a detection rate of 0.1–4.3% for incidental findings of thyroid focal uptake identified by (18)F-fluorodeoxyglugose Positron Emission Tomography with computed tomography ((18)FDG-PET/CT) initially prescribed for nonthyroid disease. From 10.3 to 80.0% of patients who underwent further evaluation are diagnosed with malignant lesions. Our first objective is to determine the risk of malignancy confined in thyroid incidentalomas(IT) detected on (18)FDG-PET/CT in patients treated in a tertiary care center (Centre Hospitalier Universitaire de Sherbrooke). Second, we want to identify a cut-off value for SUVmax in order to distinguish benign from malignant IT. Third, we look for predictive criterion that can be outlined to help in their management. METHODS: We retrospectively reviewed 40 914 charts of patients who had a (18)FDG-PET/CT done in a tertiary center from 2004 to 2014. For each patient where a thyroid incidentaloma has been identified, Maximum Standardized Uptake Value (SUVmax), ultrasound report, cytology and histopathological results as well as oncologic outcomes were compiled and analyzed. RESULTS: In this study, the incidence for thyroid incidentaloma detected with (18)FDG-PET/CT is 0.74%. The rate of malignancy present in IT is 8.2% based on histopathological results. Of the patients who underwent surgery, thyroid malignancy was identified in 54.3% of them. Cytoponction showed a strong correlation with final histopathological results (p = 0.009). CONCLUSION: Thyroid incidentalomas detected with (18)FDG-PET/CT are relatively infrequent, but the potential risk of malignancy remains elevated. Fine needle aspiration biopsy is the investigation of choice to rule out a malignant incidentaloma when there is no other element in the clinical portrait to preclude such additional work up. BioMed Central 2017-03-21 /pmc/articles/PMC5359908/ /pubmed/28320460 http://dx.doi.org/10.1186/s40463-017-0200-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Hagenimana, N.
Dallaire, J.
Vallée, É.
Belzile, M.
Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
title Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
title_full Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
title_fullStr Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
title_full_unstemmed Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
title_short Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
title_sort thyroid incidentalomas on 18fdg-pet/ct: a metabolico-pathological correlation
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359908/
https://www.ncbi.nlm.nih.gov/pubmed/28320460
http://dx.doi.org/10.1186/s40463-017-0200-8
work_keys_str_mv AT hagenimanan thyroidincidentalomason18fdgpetctametabolicopathologicalcorrelation
AT dallairej thyroidincidentalomason18fdgpetctametabolicopathologicalcorrelation
AT valleee thyroidincidentalomason18fdgpetctametabolicopathologicalcorrelation
AT belzilem thyroidincidentalomason18fdgpetctametabolicopathologicalcorrelation